MEI Pharma Stock Surges 50% After $100 Million Litecoin Investment
-
最新报道：MEI Pharma's stock surged over 50% after announcing a $100 million investment in Litecoin (LTC) as part of its treasury diversification strategy. The biopharmaceutical company revealed plans to allocate a portion of its cash reserves into the cryptocurrency, citing Litecoin's established network and lower volatility compared to other digital assets. MEI Pharma CEO David Urso stated the move reflects the company's forward-looking approach to capital management while maintaining focus on oncology drug development. The investment represents one of the largest corporate crypto allocations by a publicly traded biotech firm, sparking discussions about institutional adoption in the Web3 space. Litecoin's price rose approximately 15% following the announcement.
下一篇
Companies could 'take advantage' and raise prices as tariff story plays out, UBS economist says
- UBS economist warns that companies may exploit ongoing tariff disputes to raise prices, po...
24小时热点
热点专题
418154